Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?

被引：0
|
作者：
Dhruv Mahtta
Umair Khalid
Arunima Misra
Zainab Samad
Khurram Nasir
Salim S. Virani
机构：
[1] Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality,Health Policy, Quality & Informatics Program
[2] Effectiveness,Department of Medicine, Section of Cardiology
[3] and Safety,Section of Cardiology, Health Services Research and Development (152)
[4] Baylor College of Medicine,Department of Medicine
[5] Michael E. DeBakey Veterans Affairs Medical Center,Methodist DeBakey Heart & Vascular Center
[6] The Aga Khan University,undefined
[7] Houston Methodist Hospital,undefined
来源：
Current Atherosclerosis Reports | 2020年 / 22卷
关键词：
ASCVD; Premature ASCVD; Young; MI; PAD; IHD; ICVD; Gender disparity; Risk prognostication;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?
    Mahtta, Dhruv
    Khalid, Umair
    Misra, Arunima
    Samad, Zainab
    Nasir, Khurram
    Virani, Salim S.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (09)
  • [2] Diabetes and Cardiovascular Disease What Have We Learned In 2012?
    Cunningham, Glenn R.
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2013, 40 (03): : 290 - 292
  • [3] MitraClip Registries: what have we learned recently
    Maisano, F.
    [J]. MINERVA CARDIOANGIOLOGICA, 2013, 61 (03): : 295 - 300
  • [4] COVID-19 and cardiovascular disease: what have we learned?
    Tessitore, Elena
    Meyer, Philippe
    [J]. SWISS MEDICAL WEEKLY, 2020, 150
  • [5] Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
    El Chamieh, Carolla
    Liabeuf, Sophie
    Massy, Ziad
    [J]. TOXINS, 2022, 14 (04)
  • [6] Current Management of Atherosclerotic Renovascular Disease - What Have We Learned from ASTRAL?
    Chrysochou, Constantina
    Kalra, Philip A.
    [J]. NEPHRON CLINICAL PRACTICE, 2010, 115 (01): : E73 - E81
  • [7] CARDIOVASCULAR DISEASE RISK AND MENOPAUSE: WHAT HAVE WE LEARNED FROM SWAN?
    El Khoudary, S. R.
    [J]. CARDIOLOGY, 2018, 140 : 255 - 255
  • [8] History of gestational diabetes and future cardiovascular disease: What have we learned?
    Hsu, Cherng-Lan
    Sheu, Wayne H-H
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (06): : 1258 - 1260
  • [9] Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?
    Findlow, Jamie
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (01) : 235 - 238
  • [10] What have we learned (recently) from hard probes in PHENIX?
    Stankus, Paul
    [J]. NUCLEAR PHYSICS A, 2014, 932 : 25 - 31
12345